Home › Funds › GREAT POINT PARTNERS LLC › IBRX

GREAT POINT PARTNERS LLC position in IBRX

IMMUNITYBIO INC · Health Care

GREAT POINT PARTNERS LLC reported holding 3,000,800 shares of IBRX (IMMUNITYBIO INC) in its Q2 2026 13F filing — a position valued at US$26.3M, representing 5.52% of its reported portfolio and ranking #3 among its reported holdings. GREAT POINT PARTNERS LLC has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)3.00M sh
Reported value held$26.27M
Portfolio Weight5.52%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GREAT POINT PARTNERS LLC's IBRX position evolved

GREAT POINT PARTNERS LLC first disclosed a stake in IBRX in Q1 2026 at 3,000,800 shares (US$23.0M). The position peaked in Q2 2026 at 3,000,800 shares, worth US$26.3M. Across 2 filings, GREAT POINT PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,000,800 shares valued at US$26.3M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 3.00M $23.02M New
Q2 2026 3.00M $26.27M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IBRX and 13F data

IBRX (IMMUNITYBIO INC) is a Health Care company. 68 other funds we track also report a position in IBRX — the largest reported positions include VESTOR CAPITAL, LLC (US$12.1M), Sound Capital Solutions LLC (US$9.8M), Clearwater Capital Advisors, LLC (US$6.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IBRX

All IBRX fund holders →

FAQ

How long has GREAT POINT PARTNERS LLC held IBRX?

GREAT POINT PARTNERS LLC has disclosed IBRX holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is GREAT POINT PARTNERS LLC's current position in IBRX?

As of Q2 2026, GREAT POINT PARTNERS LLC holds 3.00M shares of IBRX (IMMUNITYBIO INC), valued at $26.27M, representing 5.52% of its reported portfolio and ranking #3.

Has GREAT POINT PARTNERS LLC been buying or selling IBRX?

In the latest 13F filing (Q2 2026), GREAT POINT PARTNERS LLC held unchanged its position in IBRX. The position peaked in Q2 2026 at 3.00M shares.

Which other funds hold IBRX?

Other major institutional holders of IBRX include VESTOR CAPITAL, LLC, Sound Capital Solutions LLC, Clearwater Capital Advisors, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.